asenapine 3.8 MG/Day 24 HR Transdermal Patch
- RxCUI
- 2261741
- RxNorm name
- asenapine 3.8 MG/Day 24 HR Transdermal Patch
- Display name
- asenapine 3.8 MG/Day 24 HR Transdermal Patch
- Full name
- asenapine 3.8 MG/Day 24 HR Transdermal Patch
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SECUADO | ASENAPINE | Noven Therapeutics, LLC | 685eaf44-5944-4f38-afba-0a4fc0b3462b | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 2261741 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 685eaf44-5944-4f38-afba-0a4fc0b3462b | asenapine 3.8 MG/Day 24 HR Transdermal Patch | SY | 13 | These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009 | 20250130 |
| 685eaf44-5944-4f38-afba-0a4fc0b3462b | 24 HR asenapine 0.158 MG/HR Transdermal System | SCD | 13 | These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009 | 20250130 |
| 685eaf44-5944-4f38-afba-0a4fc0b3462b | asenapine 3.8 MG/Day 24HR Transdermal System | PSN | 13 | These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 2009 | 20250130 |